Fox Business - The Power to Prosper
Search Site

Biotechnology

Sell in April and go away?

The Price Futures Group senior analyst Phil Flynn, WSJ special writer Gregory Zuckerman and FBN’s Adam Shapiro on the outlook for stocks and the economic impact of low oil prices.

Read More

  1. Economy grows 2.2% in 4Q

    Hedgeye Risk Management CEO Keith McCullough discusses U.S. GDP growth.

  2. Opportunities for growth in today’s market

    Hedgeye Risk Management CEO Keith McCullough and JPM Private Bank West Coast Director of Fixed Income Heather Loomis discuss the markets and economy.

  3. How to create a wealthy portfolio

    UBS Deputy Chief U.S. Economist Drew Matus and EisnerAmper Personal Wealth Chairman Tim Speiss discuss the state of the markets and how to diversify your portfolio.

  4. Best tech plays

    Phil Flynn of The Price Future Group and Jones Trading Chief Market Strategist Mike O’Rourke discuss what’s fueling oil’s two-day rally.

  5. Energy stocks get boost from weaker dollar, rise in oil prices

    FBN’s Nicole Petallides on the highlights from the day in the markets.

  6. Kraft shares jump more than 35% on Heinz deal

    Claman on Call: FBN’s Cheryl Casone with an after-hours web exclusive on the markets, the outlook for oil and Kraft’s merger with Heinz.

  7. Kraft shares get boost from Heinz deal

    FBN’s Nicole Petallides breaks down the day in the markets.

  8. Which sectors are leading the markets?

    Capital Wave Forecast's Shah Gilani on the food and tech markets.

  9. Buy financials and technology?

    Ralph Acampora of Altaira Wealth Management argues you need to be more stock and sector specific when it comes to investing.

  10. How to build a winning portfolio

    FBN’s Charles Payne, NewOak Capital President James Frischling, Belpointe Asset Management Chief Strategist David Nelson, Plimsoll Mark Capital Managing Director Jim Awad, on the steps to building a strong portfolio.

  11. 17-year old runs a hedge fund: What’s he investing in?

    Wohl Capital Investment Group founder Jacob Wohl joins the Making Money panel to discuss how he got his early start investing and the opportunities for investors in the biotech sector.

  12. Charles Payne’s hot stock of the day: Biogen

    FBN’s Charles Payne on the markets and the outlook for Biogen.

  1. Tips for investing in biotech

    JMP Securities President Mark Lehmann discusses where he sees opportunity in the biotech industry.

  2. Quest Diagnostics, Quintiles CEOs talk clinical trial deal

    Quest Diagnostics CEO Steve Rusckowski and Quintiles CEO Tom Pike discuss their clinical trial joint venture.

  3. What the UnitedHealth-Catamaran deal means for consumers

    Manhattan Institute Scholar Avik Roy on the impact of the UnitedHealth deal to buy Catamaran.

  4. When will the economy bounce back?

    Canaccord Genuity Equity Strategist Tony Dwyer and JPMorgan Chase Chief Economist Anthony Chan discuss the Fed, economy and their outlook for the markets

  5. Unemployment outlook

    Canaccord Genuity Equity Strategist Tony Dwyer and JPMorgan Chase Chief Economist Anthony Chan discuss where to put new money to work and their outlook for March jobs numbers.

  6. How the Middle East impacts your investments

    FBN’s Liz MacDonald and Simon Constable of The Wall Street Journal discuss how turmoil in Yemen impact the oil and energy market.

  7. Navigating the markets

    BNP Paribas Head of Equity Cash Trading Darren Wolfberg discusses the final reading on GDP, and the state of the markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL